Kezdőlap › Multiplex mielóma › New York › New York City
Multiplex mielóma klinikai vizsgálatok: New York City, NY
60 Multiplex mielóma vizsgálat keres résztvevőket New York City és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Toborzás folyamatban2. fázis
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Toborzás folyamatban
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Limited-duration Teclistamab
Toborzás folyamatban2. fázis
- Columbia University, New York
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Toborzás folyamatban2. fázis
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Toborzás folyamatban3. fázis
- Research Site, New York
- Research Site, New York
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Toborzás folyamatban1. fázis
- Icahn School of Medicine at Mt. Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Toborzás folyamatban1/2. fázis
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Toborzás folyamatban4. fázis
- Mount Sinai Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban3. fázis
- Mount Sinai Chelsea, New York
- Laura and Isaac Perlmutter Cancer Center NYU ACC, New York
- Icahn School of Medicine at Mount Sinai, New York
- és további 1
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban3. fázis
- NYU Langone Health Manhattan, New York
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Toborzás folyamatban3. fázis
- Memorial Sloan Kettering Cancer Center, New York
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Toborzás folyamatban1. fázis
- Research Site, New York
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Toborzás folyamatban2. fázis
- Icahn School of Medicine at Mt. Sinai, New York
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Toborzás folyamatban3. fázis
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center-Main Campus, New York
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1/2. fázis
- Memorial Sloan Kettering, New York
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban2. fázis
- Mount Sinai Medical Center, New York
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Toborzás folyamatban3. fázis
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1/2. fázis
- Tisch Cancer Institute at Mount Sinai, New York
- Memorial Sloan-Kettering Cancer Center, New York
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Toborzás folyamatban2. fázis
- Manhattan Eye, Ear, and Throat Hospital, New York
- Staten Island University Hospital, New York
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Toborzás folyamatban2/3. fázis
- Icahn School of Medicine at Mount Sinai /ID# 277844, New York
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 277946, New York
- Weill Cornell Medicine Myeloma Center /ID# 278216, New York
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Toborzás folyamatban3. fázis
- David H. Koch Center for Cancer Care, New York
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Toborzás folyamatban1/2. fázis
- Mount Sinai, The Tisch Cancer Instutute, New York
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Toborzás folyamatban3. fázis
- Weill Cornell Medical College, New York
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban2. fázis
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
Toborzás folyamatban2. fázis
- Icahn School of Medicine at Mount Sinai, New York
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Toborzás folyamatban1/2. fázis
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214, New York
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai，The Tisch Cancer Institute, New York
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Toborzás folyamatban3. fázis
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Toborzás folyamatban1/2. fázis
- Research Site, New York
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Memorial Sloan-Kettering Cancer Center, New York
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Toborzás folyamatban1. fázis
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Toborzás folyamatban1/2. fázis
- Research Site, New York
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Toborzás folyamatban3. fázis
- Research Site, New York
- Research Site, New York
- Research Site, New York
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Toborzás folyamatban1. fázis
- Memorial Sloan Kettering Cancer Center, New York
Delayed Toxicities Post-CAR-T
Toborzás folyamatbanMegfigyeléses tanulmány
- Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Toborzás folyamatbanMegfigyeléses tanulmány
- Weill Cornell Medical Center (Data Analysis Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Toborzás folyamatban2. fázis
- The Tisch Cancer Institute/Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Toborzás folyamatban1/2. fázis
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Toborzás folyamatban1/2. fázis
- Mount Sinai - The Tisch Cancer Institute /ID# 272470, New York
- Weill Cornell Medical College /ID# 272517, New York
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Laura and Isaac Perlmutter Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Mt Sinai /ID# 251166, New York
- Memorial Sloan Kettering Cancer Center-Koch Center /ID# 251167, New York
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Toborzás folyamatban1. fázis
- Weill Cornell Medicine/New York Presbyterian Hospital, New York
- New York Presbyterian Hospital Columbia University Medical Center, New York
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Toborzás folyamatban2. fázis
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Toborzás folyamatban2. fázis
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
The Ambient Light Multiple Myeloma Study
Toborzás folyamatban
- Icahn Schoool of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Toborzás folyamatban3. fázis
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Toborzás folyamatban
- Icahn School of Medicine at Mount Sinai, New York
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Toborzás folyamatban3. fázis
- Mount Sinai Medical Center - 2, New York
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Toborzás folyamatban1/2. fázis
- Perlmutter Cancer Center, New York
- Columbia University _ New York Presbyterian, New York
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 270282, New York
A Dietary Study for People With Multiple Myeloma
Toborzás folyamatban
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Toborzás folyamatban3. fázis
- GSK Investigational Site, New York
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1/2. fázis
- Icahn School of Medicine at Mount Sinai, New York
Study of CAR-T Therapy in Older Patients
Toborzás folyamatbanMegfigyeléses tanulmány
- Memorial Sloan Kettering Cancer Center, New York
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Toborzás folyamatban2. fázis
- Memorial Sloan Kettering Cancer Center, New York
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
Toborzás folyamatbanKorai 1. fázis
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Memorial Sloan Kettering Cancer Center, New York
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1/2. fázis
- Memorial Sloan Kettering Cancer Center, New York
Multiplex mielóma vizsgálatok más városokban
- Boston, MA42 tanulmány
- Atlanta, GA42 tanulmány
- Houston, TX38 tanulmány
- Durham, NC37 tanulmány
- Nashville, TN32 tanulmány
- Denver, CO27 tanulmány
- Rochester, MN24 tanulmány
- St. Louis, MO24 tanulmány
- Columbus, OH24 tanulmány
- Baldwin Park, CA23 tanulmány
- Edison, NJ22 tanulmány
- Chicago, IL22 tanulmány
Egyéb vizsgálatok: New York City
- Mellrák136 tanulmány
- Nem kis sejtes tüdőrák121 tanulmány
- Rák (minden típus)109 tanulmány
- Prosztatarák103 tanulmány
- Áttétes rák93 tanulmány
- Kolorektális rák78 tanulmány
- Petefészekrák69 tanulmány
- Tüdőrák60 tanulmány
- Hasnyálmirigyrák60 tanulmány
- Endometriális rák52 tanulmány
- Akut mieloid leukémia51 tanulmány
- Szívelégtelenség51 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.